Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Inventory (2016 - 2023)

Lexaria Bioscience's Inventory history spans 9 years, with the latest figure at $7588.0 for Q1 2023.

  • Quarterly results put Inventory at $7588.0 for Q1 2023, down 76.23% from a year ago — trailing twelve months through Feb 2023 was $7588.0 (down 76.23% YoY), and the annual figure for FY2022 was $38418.0, up 29.58%.
  • Inventory for Q1 2023 was $7588.0 at Lexaria Bioscience, down from $9936.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $188275.0 in Q2 2019 to a low of -$6067.0 in Q4 2020.
  • The 5-year median for Inventory is $51738.0 (2021), against an average of $75001.1.
  • The sharpest move saw Inventory plummeted 104.54% in 2020, then surged 240.97% in 2022.
  • Year by year, Inventory stood at $133556.0 in 2019, then plummeted by 104.54% to -$6067.0 in 2020, then skyrocketed by 148.03% to $2914.0 in 2021, then surged by 240.97% to $9936.0 in 2022, then fell by 23.63% to $7588.0 in 2023.
  • According to Business Quant data, Inventory over the past three periods came in at $7588.0, $9936.0, and $38418.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.